Related references
Note: Only part of the references are listed.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
I-Yin Chen et al.
FRONTIERS IN MICROBIOLOGY (2019)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
A novel mechanism of antibody-mediated enhancement of flavivirus infection
Denise Haslwanter et al.
PLOS PATHOGENS (2017)
Complement-targeted therapy: development of C5- and C5a-targeted inhibition
Takahiko Horiuchi et al.
INFLAMMATION AND REGENERATION (2016)
Primary Severe Acute Respiratory Syndrome Coronavirus Infection Limits Replication but Not Lung Inflammation upon Homologous Rechallenge
Candice Clay et al.
JOURNAL OF VIROLOGY (2012)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLOS ONE (2012)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2010)
Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia
Hong Peng Jia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Anti-inflammatory actions of intravenous immunoglobulin
Falk Nimmerjahn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice
Yumiko Imai et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry
Shiori Haga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2
Shunxin Wang et al.
VIRUS RESEARCH (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Monoclonal antibodies capable of discriminating the human inhibitory Fcγ-receptor IIB (CD32B) from the activating Fcγ-receptor IIA (CD32A):: biochemical, biological and functional characterization
Maria-Concetta Veri et al.
IMMUNOLOGY (2007)
Angiotensin-converting enzyme 2 in lung diseases
Keiji Kuba et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals
LQ Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Tumor necrosis factor-α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)
DW Lambert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Multiple organ infection and the pathogenesis of SARS
J Gu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells
SL Fink et al.
INFECTION AND IMMUNITY (2005)
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
CK Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
IVIg-mediated amelioration of murine ITP via FcγRIIb is not necessarily independent of SHIP-1 and SHP-1 activity
E van Mirre et al.
BLOOD (2004)
Antibody-dependent enhancement of Ebola virus infection
A Takada et al.
JOURNAL OF VIROLOGY (2003)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris et al.
LANCET (2003)
Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications
A Takada et al.
REVIEWS IN MEDICAL VIROLOGY (2003)
Share Paper
